Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study

Table 6 Discriminative accuracy of adiponectin, insulin, BMI and waist circumference in the prediction of prevalent metabolic syndrome

		AUC	95 % CI
MetS-IDF	Adiponectin	0.744	0.685–0.801
	Insulin	0.783	0.730–0.837
	BMI	0.752	0.688–0.815
	Waist circumference	0.798	0.743–0.853
	Adiponectin and insulin	0.813	0.760–0.858
	Adiponectin and BMI	0.793	0.734–0.850
	Adiponectin and waist circumference	0.825	0.767–0.883
	Adiponectin and insulin and BMI	0.829	0.780–0.874
	Adiponectin and insulin and waist circumference	0.858	0.814–0.896
MetS-AHA/NHLBI	Adiponectin	0.731	0.672–0.791
	Insulin	0.789	0.734–0.843
	BMI	0.758	0.696–0.817
	Waist circumference	0.803	0.746–0.859
	Adiponectin and insulin	0.818	0.763–0.862
	Adiponectin and BMI	0.791	0.732–0.849
	Adiponectin and waist circumference	0.822	0.767–0.879
	Adiponectin and insulin and BMI	0.840	0.793–0.884
	Adiponectin and insulin and waist circumference	0.860	0.813–0.899

ISSN: 1476-511X